Home
Conditions
Previously Treated Myelodysplastic Syndrome

Clinical trial condition

Previously Treated Myelodysplastic Syndrome

Explore clinical trials studying Previously Treated Myelodysplastic Syndrome. Study availability and eligibility vary by location and protocol.

29 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Previously Treated Myelodysplastic Syndrome trial results

Recruiting

Personalized NK Cell Therapy in CBT

NCT02727803

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, +55 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome

NCT01624805

Conditions: Anemia, Anemia, Aplastic, Aplastic Anemia, +8 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma

NCT03017820

Conditions: B-Cell Non-Hodgkin Lymphoma, Blood Protein Disorders, Bone Marrow Diseases, +46 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia

NCT02115295

Conditions: Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Crisis, +36 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Ibrutinib and Lenalidomide in Treating Patients With Myelodysplastic Syndrome

NCT03359460

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: University of California Davis Comprehensive Cancer Center Sacramento, California, United States

View Trial Details

Completed

Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia

NCT00357565

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +18 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Total Marrow and Lymphoid Irradiation and Chemotherapy Before Donor Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Leukemia

NCT02446964

Conditions: Acute Myeloid Leukemia in Remission, Adult Acute Lymphoblastic Leukemia in Complete Remission, Childhood Acute Lymphoblastic Leukemia in Complete Remission, +18 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

View Trial Details

Completed

Ibrutinib and Azacitidine for Treatment of Higher Risk Myelodysplastic Syndrome

NCT02553941

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +15 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States

University of California Davis Comprehensive Cancer Center Sacramento, California, United States

University of California San Diego San Diego, California, United States

View Trial Details

Completed

Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in Remission or Relapse Undergoing Donor Stem Cell Transplant

NCT02083250

Conditions: Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Allogeneic Hematopoietic Stem Cell Transplantation Recipient, +19 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myeloid Neoplasms

NCT02756572

Conditions: Blasts 10 Percent or More of Bone Marrow Nucleated Cells, Bone Marrow Diseases, Chronic Myelomonocytic Leukemia-2, +15 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Previously Treated Myelodysplastic Syndrome

Previously Treated Myelodysplastic Syndrome trial results

Related conditions